- Study type: Randomised Clinical Trial, Treatment
- Study type descriptors: Randomised controlled trial, Single centre
- Objective: To investigate the efficacy and safety of a nasal spray, “Humer Stop Virus,” in individuals experiencing early symptoms of acute respiratory infection, irrespective of confirmed viral presence
- Number of participants enrolled: 76
- Study enrolling from to
- Study includes follow-up for 8 days
Study Data
- Adults (18-64 years)
- General population
- Elderly (≥65 years)
- Outpatient clinic
- Primary care
- SARS-CoV-2
- Influenza virus
- Influenza-like illness/Acute respiratory infection
- Pharmacological intervention
- Antivirals
External Links
Other information
If you would like to contact the Principal Investigator of the study please email: ccb@ateneo.univr.it
The data is updated up to